Navigation Links
Neurobiological Technologies Reports Second Quarter Financial Results
Date:2/11/2008

conference call on Monday, February 11, 2007 at 10:30 a.m. (ET), 7:30 a.m. (PT). Dial-in number (877) 857-6147 (U.S. and Canada) and 719-325-4822 (International). The live webcast can be accessed by going to http://investor.shareholder.com/ntii/events.cfm. A playback of the conference call will be available from 1:30 p.m. (ET) on February 11, 2007 through 11:59 p.m. (ET) on February 15, 2007. Replay number: (888) 203-1112 (U.S. and Canada) / (719) 457-0820 (international). Replay access code: 3898964.

About Neurobiological Technologies, Inc.

NTI is a biopharmaceutical company focused on developing novel agents for central nervous system conditions. The Company's most advanced product candidate is Viprinex (ancrod), a novel multi-targeted agent currently undergoing pivotal Phase 3 clinical testing for the potential treatment of acute ischemic stroke, one of the most prevalent, debilitating and costly diseases in the world for which there are few acceptable treatment options.

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties, including uncertainties regarding the timing for completion of clinical trials, obtaining approval for Viprinex, our levels of future expenditures and capital resources and our need to raise additional capital to fund our operations, as well as other risks detailed from time to time in our Annual Report of Form 10-K and other filings with the Securities and Exchange Commission. Actual results may differ materially from those projected. These forward-looking statements represent our judgment as of the date of the release. We undertake no obligation to update these forward-looking statements.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudite
'/>"/>

SOURCE Neurobiological Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Neurobiological Technologies Reports Going Concern Qualification
2. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
3. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
4. Neurobiological Technologies Announces Compliance With Nasdaq Listing Standards
5. Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
6. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
7. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
8. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
9. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. Advanced technologies aim to transform the coaching of top athletes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... Michigan Health System have been able to bring an ... from chronic obstructive pulmonary disease (COPD) by teaching them ... students are members of a pulmonary rehabilitation class at ... that people with chronic obstructive pulmonary disease can focus ...
... tiny gadgets, devices and machines can get, scientists have ... by a University of Arizona// team of optical sciences ... physics Alexander D. Cronin. ,Perreault and Cronin directly ... surface before the atoms' wavelengths change, said a statement ...
... present below the urinary bladder in males. The main function ... to the semen//. Prostate cancer is the most common cancer ... in American men. The incidence of the cancer in Asian ... an assessment of the risk factors is important. It is ...
... If you like to gorge on burgers and other ... have found a way to make it healthier//. ... and Molecular Biosciences and other researchers examined the properties ... in the Far East, South America and parts of ...
... Seasonal Affective Disorder (SAD) has been found to be affected ... emphasising the importance of sunlight for health//. ... in physical energy, increased appetite, and increased need for sleep. ... relation between melatonin and serotonin. ,Our mood is ...
... molecule is the cause of an autoimmune disease in ... disease is related to multiple sclerosis//. ,In a ... of Clinical Investigation, researchers from Johns Hopkins University School ... protein, IL-6, are dramatically elevated in the spinal fluid ...
Cached Medicine News:Health News:Nanotechnologists Specify Limitation For Devising Small Machines 2
(Date:12/15/2014)... , Dec. 15, 2014  Colorado and Washington ... legalized adult use of cannabis. Oregon , ... ended prohibition during the November 2014 elections. ... - http://photos.prnewswire.com/prnh/20141212/164153LOGO The benefits of ... and obvious benefits like the increased tax revenue for state ...
(Date:12/15/2014)... 2014   DaVita HealthCare Partners Inc.  (NYSE: ... largest and most innovative health care communities, today ... DaVita Clinical Research  (DCR) and  HealthCare Partners Clinical Research ... extensive clinical research and data analytics services, specifically ... end-stage renal disease (ESRD), as well as primary ...
(Date:12/13/2014)... , Dec. 11, 2014 Research and ... the addition of the "Drug Injection Devices ... http://photos.prnewswire.com/prnh/20130307/600769 ... of an expanding list of health conditions, drug ... that simplify the administration process and increase the ...
Breaking Medicine Technology:CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4
... of the leading cancer centers in the Middle East has ... RapidArc® radiotherapy treatments from Varian Medical Systems (NYSE: VAR). Al Amal Hospital ... and head & neck cancer patients with RapidArc since commencing treatments in ... many more indications. , , ...
... June 21 CardioGenics Holdings Inc. (OTC Bulletin Board: ... products for the immunoassay segment of the In-Vitro Diagnostics market, announced ... QL Care™ Analyzer, a portable diagnostic platform designed to produce test ... , , , ...
Cached Medicine Technology:Al Amal Hospital in Qatar Commences Treatments Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 2Al Amal Hospital in Qatar Commences Treatments Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 3CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer 2CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer 3CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer 4
Castroviejo tying forceps, tying platforms, straight, 0.3 mm teeth....
Girard curved tying forceps made of titanium has curved shafts with 8 mm tying platforms, width of shafts 0,25 mm, TCI platforms, round handle, diam. 6 mm, overall length 99 mm....
Straight tying forceps made of titanium has straight shafts with 6 mm V-grove tying platforms, width of shafts 0,5 mm, TCI platforms, flat handle, width 10 mm, overall length 105 mm....
McPherson straight tying forceps made of titanium, straight shafts with 4 mm tying platforms, width of shafts 0,25 mm, TCI platforms, flat handle, width 6 mm, overall length 87 mm....
Medicine Products: